Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis

BACKGROUND: Oncolytic viruses reduce tumor burden in animal models and have generated promising results in clinical trials. However, it is likely that oncolytic viruses will be more effective when used in combination with other therapies. Current therapeutic approaches, including chemotherapeutics,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebremeskel, Simon, Nelson, Adam, Walker, Brynn, Oliphant, Tora, Lobert, Lynnea, Mahoney, Douglas, Johnston, Brent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970295/
https://www.ncbi.nlm.nih.gov/pubmed/33722907
http://dx.doi.org/10.1136/jitc-2020-002096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970295/
https://www.ncbi.nlm.nih.gov/pubmed/33722907
http://dx.doi.org/10.1136/jitc-2020-002096

Ejemplares similares